Cargando…

Irisin Promotes Cardiac Homing of Intravenously Delivered MSCs and Protects against Ischemic Heart Injury

Few intravenously administered mesenchymal stromal cells (MSCs) engraft to the injured myocardium, thereby limiting their therapeutic efficacy for the treatment of ischemic heart injury. Here, it is found that irisin pretreatment increases the cardiac homing of adipose tissue‐derived MSCs (ADSCs) ad...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Wenjun, Chen, Youhu, Guo, Yongzhen, Xia, Yunlong, Li, Congye, Du, Yunhui, Lin, Chen, Xu, Xiaoming, Qi, Tingting, Fan, Miaomiao, Zhang, Fuyang, Hu, Guangyu, Gao, Erhe, Liu, Rui, Hai, Chunxu, Tao, Ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895138/ https://www.ncbi.nlm.nih.gov/pubmed/35038246 http://dx.doi.org/10.1002/advs.202103697

Ejemplares similares

Mesenchymal Stromal Cells Overexpressing Farnesoid X Receptor Exert Cardioprotective Effects Against Acute Ischemic Heart Injury by Binding Endogenous Bile Acids
por: Xia, Yunlong, et al.
Publicado: (2022)

Mesenchymal Stromal Cells Overexpressing Farnesoid X Receptor Exert Cardioprotective Effects Against Acute Ischemic Heart Injury by Binding Endogenous Bile Acids (Adv. Sci. 24/2022)
por: Xia, Yunlong, et al.
Publicado: (2022)

Tailorable Hydrogel Improves Retention and Cardioprotection of Intramyocardial Transplanted Mesenchymal Stem Cells for the Treatment of Acute Myocardial Infarction in Mice
por: Chen, Youhu, et al.
Publicado: (2020)

CSF2RB overexpression promotes the protective effects of mesenchymal stromal cells against ischemic heart injury
por: Qi, Tingting, et al.
Publicado: (2023)

BDNF-overexpressing MSCs delivered by hydrogel in acute ischemic stroke treatment
por: Wang, Congxiao, et al.
Publicado: (2022)

Fas-Activated Serine/Threonine Kinase Governs Cardiac Mitochondrial Complex I Functional Integrity in Ischemia/Reperfusion Heart
por: Chen, Xiyao, et al.
Publicado: (2021)

The Myokine Irisin Promotes Osteogenic Differentiation of Dental Bud-Derived MSCs
por: Posa, Francesca, et al.
Publicado: (2021)

Branched chain amino acids exacerbate myocardial ischemia/reperfusion vulnerability via enhancing GCN2/ATF6/PPAR-α pathway-dependent fatty acid oxidation
por: Li, Yueyang, et al.
Publicado: (2020)

The Neuroprotective Effect of Irisin in Ischemic Stroke
por: Liu, Yaqiang, et al.
Publicado: (2020)

Excessive branched-chain amino acid accumulation restricts mesenchymal stem cell-based therapy efficacy in myocardial infarction
por: Zhang, Fuyang, et al.
Publicado: (2022)

Suppressing Mesenchymal Stromal Cell Ferroptosis Via Targeting a Metabolism‐Epigenetics Axis Corrects their Poor Retention and Insufficient Healing Benefits in the Injured Liver Milieu
por: Hu, Guangyu, et al.
Publicado: (2023)

Suppressing Mesenchymal Stromal Cell Ferroptosis Via Targeting a Metabolism‐Epigenetics Axis Corrects their Poor Retention and Insufficient Healing Benefits in the Injured Liver Milieu (Adv. Sci. 13/2023)
por: Hu, Guangyu, et al.
Publicado: (2023)

LRRC8A critically regulates myofibroblast phenotypes and fibrotic remodeling following myocardial infarction
por: Chen, Xiyao, et al.
Publicado: (2022)

Pretreatment of Diabetic Adipose-derived Stem Cells with mitoTEMPO Reverses their Defective Proangiogenic Function in Diabetic Mice with Critical Limb Ischemia
por: Lian, Kun, et al.
Publicado: (2019)

Neovascularization: The Main Mechanism of MSCs in Ischemic Heart Disease Therapy
por: Shi, Weili, et al.
Publicado: (2021)

Early Post-Stroke Electroacupuncture Promotes Motor Function Recovery in Post-Ischemic Rats by Increasing the Blood and Brain Irisin
por: Liu, Li, et al.
Publicado: (2021)

Exosome–Liposome Hybrid Nanoparticles Deliver CRISPR/Cas9 System in MSCs
por: Lin, Yao, et al.
Publicado: (2018)

The Changes of Irisin and Inflammatory Cytokines in the Age-Related Macular Degeneration and Retinal Vein Occlusion
por: Li, Xiaochun, et al.
Publicado: (2022)

Modulating the distribution and fate of exogenously delivered MSCs to enhance therapeutic potential: knowns and unknowns
por: Masterson, Claire H., et al.
Publicado: (2019)

microRNAs delivered by small extracellular vesicles in MSCs as an emerging tool for bone regeneration
por: Liu, Runyuan, et al.
Publicado: (2023)

Association between serum irisin concentration and ischemic stroke: From etiology to clinic
por: Çalık, Mustafa, et al.
Publicado: (2022)

Irisin promotes the proliferation and tenogenic differentiation of rat tendon-derived stem/progenitor cells via activating YAP/TAZ
por: Xu, Langhai, et al.
Publicado: (2022)

The role of MSCs and CAR-MSCs in cellular immunotherapy
por: Yan, Lun, et al.
Publicado: (2023)

Role of irisin in bone diseases
por: Zhao, Ruobing, et al.
Publicado: (2023)

Irisin attenuates myocardial ischemia/reperfusion‐induced cardiac dysfunction by regulating ER‐mitochondria interaction through a mitochondrial ubiquitin ligase‐dependent mechanism
por: Lu, Linhe, et al.
Publicado: (2020)

Irisin, an Effective Treatment for Cardiovascular Diseases?
por: Liu, Chen, et al.
Publicado: (2022)

Irisin ERKs the Fat
por: Wu, Jun, et al.
Publicado: (2014)

Irisin in Liver Cirrhosis
por: Kukla, Michał, et al.
Publicado: (2020)

Serum irisin levels are decreased in patients with sepsis, and exogenous irisin suppresses ferroptosis in the liver of septic mice
por: Wei, Shasha, et al.
Publicado: (2020)

Review of Research on the Role of Irisin in Tumors
por: Zhang, Deguo, et al.
Publicado: (2020)

MSCs Deliver Hypoxia‐Treated Mitochondria Reprogramming Acinar Metabolism to Alleviate Severe Acute Pancreatitis Injury
por: Hu, Zhengyu, et al.
Publicado: (2023)

Exercise-induced irisin in bone and systemic irisin administration reveal new regulatory mechanisms of bone metabolism
por: Zhang, Jin, et al.
Publicado: (2017)

Mesenchymal Stem Cell (MSCs) Therapy for Ischemic Heart Disease: A Promising Frontier
por: Poomani, Merlin Sobia, et al.
Publicado: (2022)

Embryonic Stem Cell‐Derived Mesenchymal Stem Cells (MSCs) Have a Superior Neuroprotective Capacity Over Fetal MSCs in the Hypoxic‐Ischemic Mouse Brain
por: Hawkins, Kate E., et al.
Publicado: (2018)

Therapeutic Strategies for IVD Regeneration through Hyaluronan/SDF-1-Based Hydrogel and Intravenous Administration of MSCs
por: Cunha, Carla, et al.
Publicado: (2021)

Repeated intravenous administration of hiPSC-MSCs enhance the efficacy of cell-based therapy in tissue regeneration
por: Sun, Si-Jia, et al.
Publicado: (2022)

Protective effect of irisin against Alzheimer’s disease
por: Chen, Kang, et al.
Publicado: (2022)

Irisin and troponin I expression in dialysis patients submitted to remote ischemic preconditioning: a pilot study
por: Gehrke, Flávia de Sousa, et al.
Publicado: (2019)

Irisin and the therapeutic benefits of exercise
por: Spiegelman, Bruce M, et al.
Publicado: (2012)

Irisin, Two Years Later
por: Novelle, Marta G., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_npalu0vtclauut5ujshmb3p7ae